We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
-13.08%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$10.3B
AUM Growth
-$4.23B
Cap. Flow
-$2.33B
Cap. Flow %
-22.54%
Top 10 Hldgs %
22.12%
Holding
1,775
New
890
Increased
241
Reduced
317
Closed
326

Top Buys

Rank Stock Value
1
CMCSA icon
Comcast
CMCSA
+$139M
2
PYPL icon
PayPal
PYPL
+$91.4M
3
BDX icon
Becton Dickinson
BDX
+$83.3M
4
HON icon
Honeywell
HON
+$79M
5
PM icon
Philip Morris
PM
+$69.3M

Top Sells

Rank Stock Value
1
ABMD
Abiomed Inc
ABMD
+$177M
2
EFX icon
Equifax
EFX
+$169M
3
MSFT icon
Microsoft
MSFT
+$163M
4
CI icon
Cigna
CI
+$159M
5
GPN icon
Global Payments
GPN
+$155M

Sector Composition

Rank Sector Weight
1 Healthcare 29.34%
2 Technology 14.72%
3 Financials 11.05%
4 Consumer Discretionary 10.74%
5 Industrials 9.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQM
1726
DELISTED
EQM Midstream Partners, LP
EQM
-34,438
Closed -$1.82M
AKRX
1727
DELISTED
Akorn Inc
AKRX
-1,022,159
Closed -$13.3M
AGN
1728
DELISTED
Allergan plc
AGN
-291,146
Closed -$55.5M
TGE
1729
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
-53,738
Closed -$1.27M
S
1730
DELISTED
Sprint Corporation
S
-17,000
Closed -$111K
AYR
1731
DELISTED
Aircastle Ltd
AYR
-51,171
Closed -$1.12M
INST
1732
DELISTED
Instructure, Inc.
INST
-10,688
Closed -$378K
INXN
1733
DELISTED
Interxion Holding N.V.
INXN
-20,300
Closed -$1.37M
DERM
1734
DELISTED
Dermira, Inc.
DERM
-11,743
Closed -$128K
ACHN
1735
DELISTED
Achillion Pharmaceuticals
ACHN
-820,146
Closed -$3.02M
MDR
1736
DELISTED
McDermott International
MDR
-423,158
Closed -$7.8M
ARQL
1737
DELISTED
Arqule Inc
ARQL
-1,912,772
Closed -$10.8M
MLNT
1738
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
-2,423
Closed -$48K
PSDO
1739
DELISTED
Presidio, Inc. Common Stock
PSDO
-82,610
Closed -$1.26M
ONCE
1740
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
-6,567
Closed -$358K
SEMG
1741
DELISTED
SEMGROUP CORPORATION
SEMG
-34,195
Closed -$754K
CBM
1742
DELISTED
Cambrex Corporation
CBM
-8,286
Closed -$566K
AMR
1743
DELISTED
Alta Mesa Resources Inc
AMR
$0 ﹤0.01%
+8
New +$20
BT
1744
DELISTED
BT Group plc (ADR)
BT
-10,944
Closed -$162K
WP
1745
DELISTED
Worldpay, Inc.
WP
-24,183
Closed -$2.45M
SDLP
1746
DELISTED
SEADRILL PARTNERS LLC
SDLP
-1,566
Closed -$58K
LLL
1747
DELISTED
L3 Technologies, Inc.
LLL
-975
Closed -$208K
ULTI
1748
DELISTED
Ultimate Software Group Inc
ULTI
-14,374
Closed -$4.63M
IDTI
1749
DELISTED
Integrated Device Technology I
IDTI
-26,081
Closed -$1.23M
ESL
1750
DELISTED
Esterline Technologies
ESL
-4,430
Closed -$403K

Similar funds

Marshall Wace North America's Q4 2018 Portfolio in Review

As of Q4 2018, Marshall Wace North America held 1,775 positions worth $10.3B, down 29% from $14.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Marshall Wace North America withdrew a net $2.33B in Q4 2018, closing 326 positions and reducing 317 holdings. Its most notable exit was Equifax, an estimated $169M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Marshall Wace North America opened a new position in PayPal worth $92.3M.

  • Marshall Wace North America's largest Q4 2018 buy was PayPal: 1,097,757 shares worth $92.3M.
  • Marshall Wace North America added most to Comcast in Q4 2018, an estimated $139M increase.
  • Marshall Wace North America's biggest Q4 2018 reduction was Abiomed Inc, cutting an estimated $177M.
  • Marshall Wace North America fully exited Equifax in Q4 2018, selling an estimated $169M.
  • Marshall Wace North America's ten largest holdings make up 22% of its $10.3B portfolio in Q4 2018.
  • Marshall Wace North America opened 890 new positions and closed 326 in Q4 2018.
  • Marshall Wace North America's portfolio value fell 29% quarter-over-quarter to $10.3B.

Based on Marshall Wace North America's 13F filing for Q4 2018, filed 14 Feb 2019.